Infectious Coryza in Chickens: Drugs, Treatment Protocols, and Differential Diagnosis

Introduction

Infectious coryza is an acute respiratory disease of chickens caused by the bacterium Avibacterium paragallinarum (formerly Haemophilus paragallinarum). The disease is characterized by serous to mucopurulent nasal discharge, facial edema, conjunctivitis, and decreased egg production in layers [1, 2]. Morbidity is high in affected flocks, often reaching 80-100%, while mortality is typically low unless complicated by secondary pathogens [3]. The economic impact of infectious coryza is substantial, particularly in multi-age layer and broiler breeder operations, where the disease can cause prolonged production losses and increased culling rates [2, 3].

This article provides a detailed examination of the drugs, treatment protocols, and differential diagnostic approaches for infectious coryza in chickens, with emphasis on antimicrobial susceptibility patterns, vaccine adjuvant technologies, and molecular diagnostic methods.

Etiology and Pathogenesis

Avibacterium paragallinarum is a Gram-negative, non-motile, pleomorphic coccobacillus that requires nicotinamide adenine dinucleotide (NAD, V factor) for growth [4, 3]. The bacterium is classified into three serogroups (A, B, and C) based on Page's hemagglutination scheme, with multiple serovars within each group [5]. Serovar distribution varies geographically, and cross-protection between serovars is incomplete, which complicates vaccine development [5, 6].

The pathogen colonizes the upper respiratory tract, specifically the nasal passages, sinuses, and conjunctival mucosa [1]. Adhesion to ciliated epithelial cells is mediated by fimbriae and other surface adhesins. The bacterium produces a polysaccharide capsule that inhibits phagocytosis and a hemagglutinin that contributes to virulence [2]. Following colonization, the host inflammatory response leads to edema, heterophil infiltration, and mucus hypersecretion, which manifest clinically as facial swelling and nasal discharge [1, 3].

Antimicrobial Drugs and Susceptibility Patterns

Classes of Antimicrobial Agents

Treatment of infectious coryza relies on antimicrobial agents that achieve therapeutic concentrations in the upper respiratory tract. The most commonly used drug classes include:

1. Beta-lactams: Amoxicillin, ampicillin, and ceftiofur are frequently employed. Beta-lactams inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) [2, 3].

2. Macrolides: Tylosin, tilmicosin, and erythromycin act by binding to the 50S ribosomal subunit, inhibiting protein synthesis. These drugs concentrate well in respiratory tissues [3].

3. Tetracyclines: Oxytetracycline and doxycycline inhibit the 30S ribosomal subunit and are commonly administered via drinking water or feed [2].

4. Fluoroquinolones: Enrofloxacin and norfloxacin inhibit DNA gyrase and topoisomerase IV. These agents have broad Gram-negative activity but are subject to regulatory restrictions in some regions [2].

5. Sulfonamides and potentiated sulfonamides: Trimethoprim-sulfamethoxazole inhibits sequential steps in folate synthesis and is available in water-soluble formulations [3].

Antimicrobial Resistance

Antimicrobial resistance in A. paragallinarum is an emerging concern. Cao et al. [2] conducted a genomic-based antimicrobial resistance analysis of isolates from Guangdong Province, China, and identified resistance determinants against tetracyclines (tet genes), beta-lactams (bla genes), and sulfonamides (sul genes). The study reported that 68% of isolates were multidrug-resistant, defined as resistance to three or more antimicrobial classes [2]. Nouri et al. [3] isolated A. paragallinarum from backyard chickens in Iran and found high resistance rates to streptomycin (82%), tylosin (71%), and oxytetracycline (65%), while ceftiofur and enrofloxacin retained higher efficacy.

These findings underscore the necessity of performing antimicrobial susceptibility testing (AST) prior to treatment selection [2, 3]. Disk diffusion and broth microdilution methods, following Clinical and Laboratory Standards Institute (CLSI) guidelines, are recommended for determining minimum inhibitory concentrations (MICs) for A. paragallinarum [2, 3].

Alternative and Adjunctive Therapies

Probiotics and Berry Phenolic Extracts: Thapa et al. [1] investigated the combination of probiotics with berry phenolic extracts against A. paragallinarum. The study demonstrated synergistic antibacterial activity, with the phenolic compounds disrupting bacterial cell membranes and the probiotics competing for adhesion sites on the respiratory epithelium [1]. This approach may reduce reliance on conventional antibiotics [1].

Chinese Herbal Medicine Extracts: Yue et al. [7] evaluated the bacteriostatic effects of extracts from Scutellaria baicalensis, Coptis chinensis, and Pulsatilla chinensis against A. paragallinarum. The minimum inhibitory concentrations ranged from 3.9 to 15.6 mg/mL, with Coptis chinensis extract showing the highest activity [7]. These herbal extracts may serve as adjunctive therapies, particularly in organic production systems [7].

Disinfectants: Huberman et al. [5] evaluated the protection conferred by a commercial disinfectant (a quaternary ammonium compound) against clinical disease caused by A. paragallinarum serovars A, B, and C. The disinfectant significantly reduced bacterial load on fomites and decreased transmission between pens, supporting its use as part of a comprehensive biosecurity program [5].

Treatment Protocols

Water Medication

Water-soluble antimicrobials are the preferred route for treating large flocks due to ease of administration. The following protocols are commonly employed:

Water medication should be preceded by a period of water withdrawal (1-2 hours) to encourage rapid consumption [3]. Medicated water should be the sole source of drinking water during the treatment period [3].

Injectable Therapy

Individual bird treatment with injectable antimicrobials is reserved for valuable breeding stock or severely affected birds. Ceftiofur (1-2 mg/kg intramuscularly once daily for 3-5 days) and enrofloxacin (5-10 mg/kg subcutaneously once daily for 3 days) are commonly used [2, 3]. Injection sites should be rotated to minimize tissue damage.

Supportive Care

Supportive care includes providing adequate ventilation to reduce ammonia levels, ensuring access to clean water and feed, and reducing stocking density [5]. Non-steroidal anti-inflammatory drugs (e.g., meloxicam at 0.5 mg/kg orally) may be administered to reduce facial edema and fever, although no controlled studies have specifically evaluated their efficacy in infectious coryza.

Treatment Failure and Recurrence

Treatment failure may result from antimicrobial resistance, inadequate dosing, or reinfection from environmental reservoirs [2, 3]. A. paragallinarum can survive in nasal exudate and on fomites for several days, and carrier birds may shed the organism intermittently [5]. Complete depopulation, cleaning, disinfection, and a downtime period of 2-3 weeks are recommended for persistently infected flocks [5].

Vaccination Strategies

Vaccine Types

Inactivated (killed) vaccines are the primary means of preventing infectious coryza [8, 6, 9]. These vaccines are typically administered as oil-emulsion or double-emulsion formulations [8, 6, 9]. The choice of adjuvant significantly influences the immune response.

Oil-emulsion adjuvants: Water-in-oil (W/O) and water-in-oil-in-water (W/O/W) emulsions provide sustained antigen release and induce strong humoral immunity [8, 6]. Fukanoki et al. [8] demonstrated that the antigen release rate from W/O/W emulsion vaccines correlates directly with antibody titers, with slower release producing longer-lasting protection.

Polymeric nanocarrier adjuvants: Ibrahim et al. [10] developed polymeric nanocarrier-based adjuvants (chitosan and poly(lactic-co-glycolic acid) nanoparticles) for a locally produced mucosal coryza vaccine. The nanocarrier-adjuvanted vaccine induced significantly higher mucosal IgA and serum IgG responses compared to conventional oil-emulsion vaccines, and provided superior protection against homologous challenge [10].

Comparison of adjuvants: Reid and Blackall [9] compared several adjuvants for an inactivated infectious coryza vaccine, including aluminum hydroxide, saponin, and mineral oil. Mineral oil adjuvants induced the highest antibody titers and longest duration of protection, but also caused the most severe local reactions at the injection site [9]. Blackall et al. [6] confirmed that double-emulsion (W/O/W) adjuvants provided a favorable balance between immunogenicity and reactogenicity.

Vaccination Protocols

Breeder pullets are typically vaccinated twice before the onset of lay: once at 8-10 weeks and again at 14-16 weeks of age [8, 6]. Vaccines should contain serovars representative of the circulating field strains in the region [5]. Autogenous vaccines may be prepared from local isolates when commercial vaccines do not provide adequate coverage [6].

Limitations of Vaccination

Vaccination does not prevent colonization or shedding of A. paragallinarum; it only reduces clinical signs [5, 6]. Carrier birds may still transmit the organism to unvaccinated flockmates. Furthermore, cross-protection between serovars is limited, and vaccine breakdown can occur when a new serovar is introduced [5].

Differential Diagnosis

Infectious coryza must be differentiated from other respiratory diseases of chickens that present with similar clinical signs. The table below summarizes key differentiating features.

Molecular Diagnostic Assays

Krylova et al. [4] developed and validated PCR diagnostic assays for the detection of A. paragallinarum and O. rhinotracheale. The assays target the HA gene (hemagglutinin) of A. paragallinarum and the 16S rRNA gene of O. rhinotracheale [4]. The PCR assays demonstrated 100% analytical specificity and a limit of detection of 10 colony-forming units per reaction [4]. These assays are particularly useful for differentiating infectious coryza from other respiratory pathogens in mixed infections.

Diagnostic Workflow

The following Mermaid diagram illustrates a recommended diagnostic workflow for a chicken flock presenting with respiratory signs.

flowchart TD
    A["Flock presents with respiratory signs: facial edema, nasal discharge, conjunctivitis"] --> B{Clinical history and gross lesions}
    B --> C["Collect samples: nasal swabs, sinus exudate, tracheal swabs"]
    C --> D[Perform PCR for A. paragallinarum, M. gallisepticum, IBV, AIV, NDV]
    D --> E{Results}
    E -->|A. paragallinarum positive| F[Infectious coryza confirmed]
    E -->|Multiple pathogens detected| G[Mixed infection likely]
    E -->|All negative| H[Consider bacterial culture and AST]
    F --> I[Initiate antimicrobial therapy based on AST]
    G --> J["Treat primary pathogen; manage secondary infections"]
    H --> K["Rule out non-infectious causes: ammonia, dust, allergens"]
    I --> L["Monitor clinical response; re-test if no improvement"]
    J --> L
    L --> M[Implement biosecurity and vaccination program]

Sample Collection and Transport

For PCR and bacterial culture, samples should be collected from acutely affected birds (within 24-48 hours of clinical onset) [4, 3]. Nasal swabs and sinus exudate are preferred over tracheal swabs, as A. paragallinarum is most abundant in the upper respiratory tract [4]. Swabs should be placed in transport medium (e.g., Amies with charcoal) and kept at 4 degrees Celsius during transport [3]. For culture, samples should be plated within 24 hours on chocolate agar supplemented with NAD (V factor) and incubated in 5-10% carbon dioxide at 37 degrees Celsius for 24-48 hours [3].

Prevention and Control

Biosecurity

Infectious coryza is transmitted horizontally via direct contact, aerosolized droplets, and contaminated fomites [5]. Strict biosecurity measures include:

• All-in/all-out flock management
• Dedicated footwear and clothing for each house
• Disinfection of equipment and vehicles entering the farm
• Control of wild birds and rodents
• Quarantine of newly introduced birds for at least 30 days [5]

Disinfection

Huberman et al. [5] demonstrated that a quaternary ammonium disinfectant applied at a 1:200 dilution effectively inactivated A. paragallinarum on contaminated surfaces within 10 minutes of contact time. Phenolic and chlorine-based disinfectants are also effective, but organic matter (e.g., feces, feed) can reduce their activity [5].

Eradication

Eradication of infectious coryza from a multi-age facility is challenging due to the carrier state [5]. Depopulation of all birds, thorough cleaning and disinfection, and a downtime period of 2-3 weeks are recommended before restocking [5]. Sentinel birds may be introduced to confirm that the facility is free of A. paragallinarum before repopulating with the full flock [5].

Conclusion

Infectious coryza remains a significant respiratory disease of chickens worldwide, causing economic losses through reduced egg production, increased culling, and treatment costs. Effective management requires accurate diagnosis using PCR and culture methods, antimicrobial therapy guided by susceptibility testing, and vaccination with appropriately adjuvanted vaccines containing relevant serovars. The emergence of multidrug-resistant A. paragallinarum strains underscores the need for alternative strategies, including probiotics, herbal extracts, and improved vaccine adjuvants. Strict biosecurity and disinfection protocols are essential for preventing introduction and spread of the pathogen.

References

[1] Thapa K, Phan A, Lin S et al. Implication of probiotics with berry phenolic extracts against Avibacterium paragallinarum. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42097187/

[2] Cao X, Huang X, Lin Y et al. Prevalence and genomic-based antimicrobial resistance analysis of Avibacterium paragallinarum isolates in Guangdong Province, China. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38652951/

[3] Nouri A, Bashashati M, Mirzaie SG et al. Isolation, Identification and Antimicrobial Susceptibility of Avibacterium paragallinarum from Backyard Chicken in Retail Markets of Karaj and Tehran Cities, Iran. Arch Razi Inst. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/35096340/

[4] Krylova E, Bogomazova A, Kirsanova N et al. Development and Validation of PCR Diagnostic Assays for Detection of Avibacterium paragallinarum and Ornithobacterium rhinotracheale. Vet Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/38250913/

[5] Huberman YD, Bueno DJ, Terzolo HR. Evaluation of the protection conferred by a disinfectant against clinical disease caused by Avibacterium paragallinarum serovars A, B, and C from Argentina. Avian Dis. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/16405005/

[6] Blackall PJ, Eaves LE, Rogers DG et al. An evaluation of inactivated infectious coryza vaccines containing a double-emulsion adjuvant system. Avian Dis. 1992. URL: https://pubmed.ncbi.nlm.nih.gov/1417593/

[7] Yue Z, Li Y, Chen L et al. Study on bacteriostasis of Chinese herbal medicine extracts to Avibacterium paragallinarum. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41579597/

[8] Fukanoki S, Matsumoto K, Mori H et al. Relationship between antigen release and antibody response of infectious coryza water-in-oil-in-water emulsion vaccines. Avian Dis. 2000. URL: https://pubmed.ncbi.nlm.nih.gov/11195641/

[9] Reid GG, Blackall PJ. Comparison of adjuvants for an inactivated infectious coryza vaccine. Avian Dis. 1987. URL: https://pubmed.ncbi.nlm.nih.gov/3579795/

[10] Ibrahim HM, Mohammed GM, Sayed RH et al. Polymeric nanocarrier-based adjuvants to enhance a locally produced mucosal coryza vaccine in chicken. Sci Rep. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38961116/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.